Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Buy
+1,778
New +$220K ﹤0.01% 6610
2025
Q3
Sell
-10,700
Closed -$1.67M 11042
2025
Q2
$1.67M Buy
+10,700
New +$1.7M ﹤0.01% 4995
2025
Q1
Sell
-11,000
Closed -$1.79M 10788
2024
Q4
$1.79M Hold
11,000
﹤0.01% 4827
2024
Q3
$2.15M Sell
11,000
-27,000
-71% -$4.97M ﹤0.01% 3919
2024
Q2
$6.59M Buy
+38,000
New +$6.32M ﹤0.01% 2593
2023
Q1
Sell
-29,300
Closed -$4.29M 10507
2022
Q4
$4.29M Buy
+29,300
New +$4.34M ﹤0.01% 2652
2019
Q4
Sell
-50,000
Closed -$6.23M 8463
2019
Q3
$6.23M Buy
+50,000
New +$6.04M ﹤0.01% 2177
2018
Q1
Sell
-11,700
Closed -$843K 8221
2017
Q4
$843K Buy
+11,700
New +$804K ﹤0.01% 3913
2016
Q4
Sell
-380,600
Closed -$19.8M 8086
2016
Q3
$19.8M Buy
380,600
+20,600
+6% +$1.04M 0.01% 989
2016
Q2
$17.1M Buy
+360,000
New +$17M 0.01% 1037
2016
Q1
Sell
-100
Closed -$5K 8278
2015
Q4
$5K Hold
100
﹤0.01% 7709
2015
Q3
$4K Sell
100
-100
-50% -$4.64K ﹤0.01% 7851
2015
Q2
$10K Sell
200
-81,700
-100% -$3.9M ﹤0.01% 7482
2015
Q1
$3.79M Buy
81,900
+60,200
+277% +$2.71M ﹤0.01% 2318
2014
Q4
$934K Buy
+21,700
New +$881K ﹤0.01% 3624

Other funds holding ZTS

UBS Group's ZTS Position: Q1 2026 in Review

UBS Group reduced its Zoetis (ZTS) stake by 0.98% in Q1 2026, selling an estimated $3.43M and leaving 2,799,543 shares worth $331M. The position accounts for 0.05% of the portfolio, ranked #385.

UBS Group first reported a position in ZTS in Q4 2014 and has held it in 46 quarters since. The position peaked at $517M in Q1 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • UBS Group held 2,799,543 shares of Zoetis worth $331M as of Q1 2026.
  • UBS Group sold 27,775 Zoetis shares in Q1 2026, an estimated $3.43M.
  • Zoetis made up 0.05% of UBS Group's portfolio in Q1 2026, its #385 holding.
  • UBS Group first reported a position in Zoetis in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Zoetis position peaked at $517M in Q1 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.